Canada needs viral hepatitis action plan
- Preventing Vertical Hepatitis C Virus Transmission. Schackman, Bruce R.; Oneda, Kawai // Clinical Infectious Diseases;9/15/2007, Vol. 45 Issue 6, p802
A letter to the editor is presented in response to the article "Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis," by CB Polis and colleagues in a previous issue.
- High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine. Aalaei-Andabili, Seyed Hossein; Alavian, Seyed Moayed // Journal of Infectious Diseases;5/1/2012, Vol. 205 Issue 9, p1472
A letter to the editor is presented in response to the article "A systematic review and meta analysis of interventions to prevent hepatitis C virus infection in people who inject drugs," by H. Hagan, E. R. Pouget and D.C. Des Jarlais in a 2011 issue of the journal.
- Reply to ''High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine''. Hagan, Holly; Jarlais, Don C. Des; Pouget, Enrique // Journal of Infectious Diseases;5/1/2012, Vol. 205 Issue 9, p1473
A response by Holly Hagan, Don C. Des Jarlais and Enrique Pouget to a letter to the editor about his article "A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs,\" in a 2011 issue of the journal, which discusses the treatment...
- Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Garcia-Tsao, Guadalupe; Lim, Joseph // American Journal of Gastroenterology;Jul2009, Vol. 104 Issue 7, p1894
A correction to the article "Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program," published in the May 19, 2009 issue, is presented.
- Hepatitis C Vaccine? Breindl, Anette // BioWorld Today;2/28/2011, Vol. 22 Issue 39, Special section p2
The article reports on a vaccine developed by researchers at the University of Copenhagen which can protect mice from developing hepatitis C.
- The silent plague. McPhee, A.T. // Current Science;9/25/98, Vol. 84 Issue 2, p4
Offers information on hepatitis C, a virus which destroys the liver. Approval of a treatment by the United States Food and Drug Administration to prevent the damages caused by the disease; Estimated amount of persons in the world infected with the disease; Effect of the disease on the liver. ...
- Berenguer J et al (Clin Infect Dis 2011; 52:728â€“36). // Clinical Infectious Diseases;Dec2012, Vol. 55 Issue 12, p1748
A correction to the article "Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus," is presented.
- Hepatitis C advances in vaccine, medicines and website. // Gastrointestinal Nursing;Feb2013, Vol. 11 Issue 1, p6
The article discusses Hepatitis C (HCV) and its vaccines. Since HCV is asymptotic, pharmaceutical company Boehringer Ingelheim has launched a website HepCRedefined.com to help patients. A team at Oxford has calculated a model to determine the spread of HCV while another team is working on...
- Eliminating hepatitis C as a public health issue. Cox, Jane // Gastrointestinal Nursing;2015 Supplement, Vol. 13 Issue Sup9, pS9
The article examines how health professionals in Great Britain can promote new drugs and treatments for eliminating the hepatitis C virus (HCV). Topics discussed include the standardization of current HCV treatments by the National Institute for Health and Care and improved cure rates resulting...